SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-016725
Filing Date
2024-01-26
Accepted
2024-01-26 16:12:52
Documents
15
Period of Report
2024-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d750299d8k.htm   iXBRL 8-K 31526
2 EX-1.1 d750299dex11.htm EX-1.1 254828
3 EX-5.1 d750299dex51.htm EX-5.1 8348
7 GRAPHIC g750299dsp50.jpg GRAPHIC 4353
  Complete submission text file 0001193125-24-016725.txt   498006

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA trml-20240125.xsd EX-101.SCH 2868
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE trml-20240125_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trml-20240125_pre.xml EX-101.PRE 11719
9 EXTRACTED XBRL INSTANCE DOCUMENT d750299d8k_htm.xml XML 3467
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40384 | Film No.: 24567876
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)